Effects of dextran sulfate on tracheal mucociliary velocity in dogs

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 13, Issue 2, 2000, Pages 87-96

  Sudo, E ^a   Boyd, W A ^a   King, Malcolm ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Dextran sulfate; Mucolytic therapy; Mucus rheology; Oligosaccharide

Indexed keywords

DEXTRAN SULFATE; MUCOLYTIC AGENT;

AEROSOL; ANIMAL EXPERIMENT; ARTICLE; COUGHING; CYSTIC FIBROSIS; DOG; DOSE RESPONSE; FEMALE; FLOW KINETICS; MALE; MOLECULAR WEIGHT; MUCOCILIARY TRANSPORT; NONHUMAN; PHYSIOTHERAPY; TRACHEA MUCUS; VISCOELASTICITY;

EID: 0033945471     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/089426800418613     Document Type: Article

References (35)

1. King, M., and B.K. Rubin. 1996. Mucus physiology and pathophysiology: Therapeutic aspects. In Derenne, J.P., W.A. Whitelaw, and T. Similowski, eds. Acute Respiratory Failure in COPD (Lung Biology in Health and Disease Series). Marcel Dekker, New York, 391-411.
2. Rubin, B.K., R.P. Tomkiewicz, and M. King. 1997. Mucoactive agents: Old and new. In Wilmott, R.W., ed. The Pediatric Lung. Birkhäuser, Basel, 155-179.
3. Sheffner, A.L. 1963. The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent, N-acetylcysteine. Ann. N.Y. Acad. Sci. 106:298-310.
4. Dasgupta, B., and M. King. 1996. Reduction in viscoelasticity of cystic fibrosis sputum in vitro with combined treatment by Nacystelyn and rhDNase. Pediatr. Pulmonol. 22:161-166.
5. App, E.M., R. Kieselmann, D. Reinhardt, H. Lindemann, B. Dasgupta, M. King, and P. Brand. 1998. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: Flutter vs. autogenic drainage. Chest 114:171-177.
6. Feng, W., H. Garrett, D.P. Speert, and M. King. 1998. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro. Am. J. Respir. Crit. Care Med. 157:710-714.
7. Wills, P.J., R.L., Hall, W.M. Chan, and P.J. Cole. 1997. Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea. J. Clin. Invest. 99:9-13.
8. King, M., B. Dasgupta, R.P. Tomkiewicz, and N.E. Brown. 1997. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with rhDNase. Am. J. Respir. Crit. Care Med. 156:173-177.
9. Shak, S., D.J. Capon, R. Hellmiss, S.A. Marsters, and C.L. Baker. 1990. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc. Natl. Acad. Sci. U.S.A. 87:9188-9192.
10. Vasconcellos, C.A., P.G. Allen, M. Wohl, J.M. Drazen, and P.A. Janmey. 1994. Reduction in sputum viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 263:969-971.
11. Daviskas, E., S.D. Anderson, J.D. Brannan, H.K. Chan, S. Eberl, and G. Bautovich. 1997. Inhalation of dry-powder mannitol increases mucociliary clearance. Eur. Respir. J. 10:2449-2454.
12. Shibuya, Y., P.J. Wills, S. Kitamura, and P.J. Cole. 1997. The effects of lactose on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum. Eur. Respir. J. 10:321s.
13. Fuchs, H.J., D.S. Borowitz, D.H. Christiansen, E.M. Morris, M.L. Nash, B.W. Ramsey, B.J. Rosenstein, A.L. Smith, and M.E. Wohl. 1994. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in cystic fibrosis. N. Engl. J. Med. 331:637-648.
14. Ranasinha, C., B. Assoufi, S. Shak, D. Christiansen, H. Fuchs, D. Empey, D. Geddes, and M. Hodson. 1993. Efficacy and safety of short-term administration of aerosolized recombinant human DNase I in adults with stable stage cystic fibrosis. Lancet 342:199-202.
15. King, M., and B.K. Rubin. 1999. Mucus controlling agents: Past and present. In Raul, J.L., ed. Aerosolized Drugs for the Respiratory Tract. Respir. Care Clinics N. Amer. Dec, 1999.
16. Feng, W., S. Nakamura, E. Sudo, M.M. Lee, A. Shao, and M. King. 1999. Effects of dextran on tracheal mucociliary velocity in dogs in vivo. Pulm. Pharmacol. Ther. 12:35-41.
17. Lee, M.M., and M. King. 1998. Effect of low molecular weight heparin on the elasticity of dog mucus. Clin. Invest. Med. 21:S102.
18. Lee, M.M., H. Garrett, E. Sudo, W.A. Boyd, and M. King. 1998. Mucociliary clearance increase due to low molecular weight heparin. Pediatr. Pulmonol. 386:S17.
19. App, E.M., J.G. Zayas, and M. King. 1993. Rheology of mucus and epithelial potential difference: Small airways vs. trachea. Eur. Respir. J. 6:67-75.
20. King, M., S. Kelly, and M. Cosio. 1985. Alteration of airway reactivity by mucus. Respir. Physiol. 62:47-59.
21. Rubin, B.K., O. Ramirez, J.G. Zayas, B. Finegan, and M. King. 1990. Collection and analysis of respiratory mucus from individuals without lung disease. Am. Rev. Respir. Dis. 141:1040-1043.
22. King, M. 1988. Magnetic microrheometer. In Braga, P.C., and L. Allegra, eds. Methods in Bronchial Mucology. Raven Press, new York, 73-83.
23. King, M. 1987. Role of mucus viscoelasticity in cough clearance. Biorheology 24:589-597.
24. Daviskas, E., S.D. Anderson, I. Gonda, S. Eberl, S. Meikle, J.P. Seale, and G. Bautovich. 1996. Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects. Eur. Respir. J. 9:725-732.
25. Robinson, M., A. Hemming, J.A. Regnis, D.L. Bailey, M. King, W. Feng, G.J. Bautovich, and P.T.P. Bye. 1998. Improved mucociliary clearance following nebulisation with hypertonic saline in adults with cystic fibrosis. In Baum, G., ed. Cilia, Mucus and Mucociliary Interactions. Marcel Dekker, New York, 265-280.
26. Tomkiewicz, R.P., W.A. Boyd, W. Feng, E.M. App, B.K. Rubin, and M. King. 1997. Tracheal clearance and mucus rheology in healthy dogs after aerosolization of 3% and 7% hypertonic saline. Am. J. Respir. Crit. Care Med. 155:A780.
27. Nakamura, S., E. Sudo, W. Feng, M.M. Lee, W.A. Boyd, and M. King. 1998. Effects of hypertonic saline aerosolization on tracheal mucus clearance and mucus rheology in healthy dogs. Eur. Respir. J. 12(S28): 180s.
28. Winters, S.L., and D.B. Yeates. 1997. Role of hydration, sodium, and chloride in regulation of canine mucociliary transport system. J. Appl. Physiol. 83:1360-1369.
29. Tomkiewicz, R.P., E.M. App, G.T. De Sanctis, M. Coeffiner, P. Maes, B.K. Rubin, and M. King. 1995. A comparison of a new mucolytic N-acetylcysteine L-lysinate with N-acetylcysteine: Airway epithelial function and mucus changes in dog. Pulm. Pharmacol. 8:259-265.
30. Sudo, E., M.M. Lee, W.A. Boyd, and M. King. 2000. Effects of methacholine and uridine 5′-triphosphate on tracheal mucus rheology in mice. Am. J. Respir. Cell Mol. Biol. 22:373-379.
31. Tai, S., H. Kai, T. Kido, Y. Isohama, K. Takahama, and T. Miyata. 1997. Effect of human neutrophil elastase on tracheal mucociliary transport in anesthetized quails. Jpn. J. Pharmacol. 75:439-442.
32. King, M., A. Ghahary, R. Franklin, M. Hirji, D. Malchenko, W.A. Boyd, H. Garrett, and M.M. Lee. 1999. Studies on aerosolized low mol. wt. heparin as a mucokinetic agent in dogs. Am. J. Respir. Crit. Care Med. 159:A474.
33. Björk, S., E. Jennische, A. Dahlstrom, and H. Ahlman. 1997. Influence of topical rectal application of drugs on dextran sulfate-induced colitis in rats. Dig. Dis. Sci. 42:824-832.
34. Lorentsen, K.J., C.W. Hendrix, J.M. Collins, D.M. Kornhauser, B.G. Petty, R.W. Klecker, C, Flexner, R.H. Eckel, and P.S. Lietman. 1989. Dextran sulfate is poorly adsorbed after oral administration. Ann. Intern. Med. 111:561-566.
35. Finlay, W.H., C.F. Lange, M. King, and D.P. Speert. 2000. Lung delivery of aerosolized dextran. Am. J. Respir. Crit. Care Med. 161:91-97.